Regulation of the Growth Hormone-Independent Growth Factor-Binding Protein in Children
- 1 November 1988
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 67 (5) , 882-887
- https://doi.org/10.1210/jcem-67-5-882
Abstract
Regulation of the diurnal variation of the GH-independent insulin-like growth factor-binding protein (BP-28) was studied in 53 children who underwent various investigations for possible endocrine abnormalities. The plasma BP-28 levels increased 12-fold from 8 .+-. 2 (.+-. SE) .mu.g/L at 2100 h to a peak level of 109 .+-. 15 .mu.g/L between 0600 and 0800 h. This rise was inversely related to plasma insulin levels and was unrelated to plasma cortisol levels. The overnight rise of plasma BP-28 was significantly altered in children who ate a light meal at 0130 h; in them BP-28 levels started to fall after 0300 h, reached nadir levels at 0400 h, began to rise again by 0700 h, and returned to control levels by 0800 h. Such changes did not occur in children given water alone. Form the peak early morning level, plasma BP-28 fell to basal levels in children given oral glucose at 0800 h; the t1/2 of the fall was 55 .+-. 9 (.+-. SE) min. In children who continued to fast, plasma BP-28 did not fall but, rather, increased from 144 .+-. 12 .mu.g/L at 0800 h after 10 h of fasting to 239 .+-. 30 .mu.g/L by 1600 h. The induction of hypoglycemia by insulin given at 0945 h after an overnight fast caused a similar but more rapid rise in plasma BP-28 to 668 .+-. 317 .mu.g/L (range, 208-1763 .mu.g/L) by 1230 h. These results suggest that the diurnal variation of plasma BP-28 concentrations in children is not due to an intrinsic rhythm, but is regulated by the metabolic status of the child.This publication has 18 references indexed in Scilit:
- Insulin-like growth factor-binding protein from human plasma. Purification and characterization.Journal of Biological Chemistry, 1986
- Placental Protein 12 Is a Decidual Protein that Binds Somatomedin and Has an Identical N-Terminal Amino Acid Sequence with Sdmatomedin-Binding Protein from Human Amhiotic Fluid*Endocrinology, 1986
- ANTIBODY AGAINST ACID-STABLE INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN DETECTS 150,000 MOL WT GROWTH HORMONE-DEPENDENT COMPLEX IN HUMAN PLASMAJournal of Clinical Endocrinology & Metabolism, 1985
- Somatomedin-C/Insulin-Like Growth Factor I-Binding Proteins in Human Amniotic Fluid and in Fetal and Postnatal Blood: Evidence of Immunological Homology*Journal of Clinical Endocrinology & Metabolism, 1985
- The Short Child with Subnormal Plasma Somatomedin CPediatric Research, 1985
- Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluidActa Endocrinologica, 1984
- Dietary components that regulate serum somatomedin-C concentrations in humans.Journal of Clinical Investigation, 1983
- Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure.Clinical Chemistry, 1982
- Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein.Proceedings of the National Academy of Sciences, 1980
- PARTIAL PURIFICATION AND CHARACTERIZATION OF A BINDING PROTEIN FOR INSULIN-LIKE ACTIVITY (ILAs) IN HUMAN AMNIOTIC FLUID: A POSSIBLE INHIBITOR OF INSULIN-LIKE ACTIVITYActa Endocrinologica, 1979